Can we embed research into clinical practice?

Can we embed research into clinical practice? Cambridge Clozapine Clinic and the study of negative symptoms in schizophrenia

A decade ago, we implemented a new model of care for people with treatment-resistant schizophrenia on clozapine. It aimed to provide excellent and cost-effective care and act as a research hub to inform clinical practice, all within a busy NHS community mental health team. The holy grail. In this talk, I’ll present the model with its achievements, benefits and risks, to then focus on one of the research lines we have developed about the characterization of the negative symptoms of schizophrenia.

Location

This is a hybrid event. 

You can attend in person: Room 109 (Hippocampus), Centre for Human Brain Health, University of Birmingham (G24 on the Campus Map).  To attend in person please register via Eventbrite: https://www.eventbrite.co.uk/e/can-we-embed-research-into-clinical-practice-tickets-516487988477

You can also attend online via Zoom.  To receive your Zoom link please register in advance via this link https://bham-ac-uk.zoom.us/webinar/register/WN_EvWcTiVgTquccPTJtcDwzw

About the Speaker

Emilio Fernandez-Egea
Cambridgeshire and Peterborough NHS Foundation Trust and
Department of Psychiatry, University of Cambridge

Emilio Fernandez-Egea is a consultant psychiatrist working in Cambridge since 2007. Clinically, he leads the Cambridge Psychosis Centre and the clozapine clinic. He is an affiliated associate professor at the Department of Psychiatry, University of Cambridge and has recently been awarded the MRC/NIHR Clinician Academic Research Partnership for studying negative symptoms of schizophrenia.